Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity-Reference-Cited by-同舟云学术

Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity

Published:2016-02-27 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sankar Mari Jeeva¹,Sankar Jhuma²,Mehta Manisha²,Bhat Vishnu³,Srinivasan Renuka⁴

Affiliation:

1. All India Institute of Medical Sciences; Newborn health Knowledge Centre, WHO Collaborating Centre for Training and Research in Newborn Care, Department of Pediatrics; Delhi India

2. All India Institute of Medical Sciences; Department of Pediatrics; New Delhi New Delhi India

3. JIPMER; Department of Pediatrics; Puducherry Puducherry India 10029

4. JIPMER; Department of Ophthalmology; Puducherry Puducherry India 110029

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD009734.pub2/fullpdf

Reference37 articles.

1. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II;Autrata;European Journal of Ophthalmology,2012

2. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial;Geloneck;JAMA Ophthalmology,2014

3. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity;Mintz-Hittner;New England Journal of Medicine,2011

4. NCT00622726 Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity (BEAT-ROP) https://clinicaltrials.gov/ct2/show/NCT00622726

5. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings;Lepore;Ophthalmology,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights in ATP Synthesis as Therapeutic Target in Cancer and Angiogenic Ocular Diseases;Journal of Histochemistry & Cytochemistry;2024-05

2. Intravitreal triamcinolone acetonide and bevacizumab injection as prevention of proliferative vitreoretinopathy in open globe injury;Bali Medical Journal;2023-05-25

3. Genetic Polymorphisms of Vascular Endothelial Growth Factor in Neonatal Pathologies: A Systematic Search and Narrative Synthesis of the Literature;Children;2023-04-19

4. DCZ19931, a novel multi-targeting kinase inhibitor, inhibits ocular neovascularization;Scientific Reports;2022-12-13

5. The analysis of foveal microvascular anomalies in retinopathy of prematurity after anti-vascular endothelial growth factor therapy on optical coherence tomography angiography;2022-08-26